Krystal Biotech Inc (KRYS)

Operating profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Operating income (ttm)	US$ in thousands	-67,587	-109,726	-147,635	-153,093	-143,798	-145,197	-132,302	-116,503	-104,143	-68,274	-56,818	-50,846	-41,407	-33,000	-28,734	-24,396	-23,332	-22,080	-18,898	-16,005
Revenue (ttm)	US$ in thousands	102,227	56,573	9,365	809	809	0	0	0	0	0	0	0	0	0	0	0	542	1,125	1,342	1,515
Operating profit margin		-66.11%	-193.95%	-1,576.45%	-18,923.73%	-17,774.78%	—	—	—	—	—	—	—	—	—	—	—	-4,304.80%	-1,962.67%	-1,408.20%	-1,056.44%

March 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-67,587K ÷ $102,227K
= -66.11%

Based on the data provided, Krystal Biotech Inc has experienced significant fluctuations in its operating profit margin over the periods indicated. The operating profit margin is a metric that reflects the proportion of revenue that translates into profit after accounting for operating expenses.

Between December 2019 and March 2020, the operating profit margin ranged from -1,056.44% to -4,304.80%, indicating that the company was incurring significant losses relative to its revenue during these periods.

However, from June 2020 to December 2023, the operating profit margin deteriorated further, reaching as low as -18,923.73% in June 2023 and -193.95% in December 2023. These negative values suggest that the company's operating expenses were surpassing its revenue by a substantial margin, leading to significant operating losses.

The most recent data point in March 2024 shows an operating profit margin of -66.11%, indicating that while the company is still facing losses, the margin has improved compared to the prior periods. It is crucial for Krystal Biotech Inc to focus on cost efficiency, revenue generation, and overall profitability to improve its operating profit margin and financial performance in the future.